Optimisation of thrombolysis treatment: where to start?

Optimisation of thrombolysis treatment: where to start?

Bibliographic Details
Main Authors:	Penaloza, M, Sheppard, J, Jowett, S, Barton, P, McManus, R, Clahrc, B
Format:	Journal article
Published:	2012

Similar Items

Cost-effectiveness of optimizing acute stroke care services for thrombolysis.
by: Penaloza-Ramos, M, et al.
Published: (2014)

Modelling the appropriate provision of specialist clinics for Transient Ischaemic Attack
by: Barton, P, et al.
Published: (2013)

Protocol for an observation and implementation study investigating optimisation of the management of stroke and transient ischaemic attack (TIA)
by: Sheppard, J, et al.
Published: (2012)

Cost-effectiveness of antihypertensive deprescribing in primary care: a Markov modelling study using data from the OPTiMISE trial
by: Jowett, S, et al.
Published: (2022)

OPtimising treatment for mild Systolic hypertension in the elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial
by: Sheppard, J, et al.
Published: (2018)

Start where you are /
by: Gardner, Chris., (Chris P.), et al.
Published: (2011)

The importance of model structure in the cost-effectiveness analysis of primary care interventions for the management of hypertension
by: Peñaloza-Ramos, M, et al.
Published: (2017)

Here Today – Where Tomorrow?
by: Barbara McManus, et al.
Published: (2008-03-01)

Where it all started
by: Long Zhang, et al.
Published: (2023-04-01)

Older people might be at most serious risk in antihypertensive treatment - reply
by: Sheppard, J, et al.
Published: (2019)

Cost-effectiveness analysis of different systolic blood pressure targets for people with a history of stroke or transient ischaemic attack: Economic analysis of the PAST-BP study.
by: Penaloza-Ramos, M, et al.
Published: (2016)

Protocols for the obvious: Where does it start, and stop?
by: Armand R. J. Girbes, et al.
Published: (2017-04-01)

Start where you are : life lessons in getting from where you are to where you want to be /
by: Gardner, Chris., (Chris P.), et al.
Published: (2009)

Blood pressure in older people after a diagnosis of hypertension
by: Sheppard, J, et al.
Published: (2023)

Varicocele and non-obstructive azoospermia – where to start?
by: A. Yu. Popova, et al.
Published: (2018-01-01)

Pyelonephritis in pregnant women: where to start?
by: S. V. Shkodkin
Published: (2019-09-01)

RESEARCH REFLECTIONS: Where to start with research
by: Kristen Haase, et al.
Published: (2015-04-01)

Looking back where it all started
by: Iveta Nohavova, et al.
Published: (2019-03-01)

Medical ethics in Libya: where to start?
by: Elmahdi A. Elkhammas
Published: (2006-11-01)

Characteristics of IVF patients before treatment: where do we start?
by: Walsh, A, et al.
Published: (2010)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease
by: Jowett, S, et al.
Published: (2017)

EdTech - Where Do I Start?
by: Nancy Caukin
Published: (2018-10-01)

Where functional MRI stops, metabolism starts
by: Polytimi Frangou, et al.
Published: (2022-04-01)

Coronary thrombolysis.
by: Cairns, J, et al.
Published: (1989)

Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study.
by: Sheppard, J, et al.
Published: (2012)

Recent advances in the treatment of chronic hepatitis B: where to start initial therapy?
by: K. V. Zhdanov
Published: (2014-09-01)

Cutting out the white coat: can we predict out of office blood pressure levels using multiple clinic measurements?
by: Sheppard, J, et al.
Published: (2012)

BENEFITS OF THROMBOLYSIS
by: Peto, R, et al.
Published: (1990)

Diagnosis and management of resistant hypertension
by: Sheppard, J, et al.
Published: (2017)

Blood pressure changes following antihypertensive medication reduction, by drug class and dose chosen for withdrawal: exploratory analysis of data from the OPTiMISE trial
by: Sheppard, J, et al.
Published: (2021)

Classification of maternal deaths: where does the chain of events start?
by: van den Akker, T, et al.
Published: (2017)

SYSTEMIC THROMBOLYSIS FOR TREATMENT OF ACUTE LIMB ISCHEMIA
by: I. P. Mikhaylov, et al.
Published: (2016-03-01)

Something for the weekend?
by: Sheppard, J, et al.
Published: (2013)

30 years of Gender Studies - where we started out and where we're headed
by: Helena Skálová
Published: (2022-01-01)

When has service provision for transient ischaemic attack improved enough? A discrete event simulation economic modelling study
by: Barton, P, et al.
Published: (2017)

Deprescribing antihypertensive medication in elderly adults - Reply
by: Sheppard, JP, et al.
Published: (2020)

Hypertension referrals from community pharmacy to general practice: multivariate logistic regression analysis of 131 419 patients
by: Albasri, A, et al.
Published: (2018)

Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients aged ≥ 80 years with hypertension: the OPTiMISE randomized clinical trial
by: Sheppard, JP, et al.
Published: (2020)

A hole revolution, or are we back where we started?
by: Pooley, O
Published: (2006)

Where science starts: Spontaneous experiments in preschoolers’ exploratory play
by: Goodman, Noah D., et al.
Published: (2017)